Five potential therapeutic agents as antidepressants: A brief review and future directions

Sheng Min Wang, Changsu Han, Soo Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Chi Un Pae

Research output: Contribution to journalReview article

2 Citations (Scopus)


Despite the availability of numerous antidepressants, many patients with depression do not show adequate response. The therapeutic lag between drug administration and onset of clinical improvement observed with conventional antidepressants has led to a need for antidepressants with a novel mechanism of action. Recently, five such agents, including acetyl-L-carnitine, scopolamine, ω-3 polyunsaturated fatty acids, ketamine, and selective 5-HT7 serotonin receptor antagonists, have gained interest as potential antidepressants with enhanced symptom control, improved tolerability, and faster onset of action compared to conventional antidepressants. This review provides an update and critical examination of these five novel therapeutic agents as potential antidepressants.

Original languageEnglish
Pages (from-to)1015-1029
Number of pages15
JournalExpert Review of Neurotherapeutics
Issue number9
Publication statusPublished - 2015 Jan 1


  • acetyl-L-carnitine
  • depression
  • ketamine
  • novel mechanism
  • scopolamine
  • selective 5-HT7 serotonin receptor antagonist
  • w-3 polyunsaturated fatty acids

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Five potential therapeutic agents as antidepressants: A brief review and future directions'. Together they form a unique fingerprint.

  • Cite this